Latest Ubiquitin Research

Explore groundbreaking studies, reviews, and discoveries in ubiquitination pathways

Research Articles

Shattering Cancer's Shield: The Revolutionary Bispecific Antibodies That Degrade c-MET in NSCLC

Discover how c-MET degrading bispecific antibodies (EpiTACs) are revolutionizing treatment for NSCLC and other c-MET driven tumors through targeted protein degradation.

Wyatt Campbell
Aug 23, 2025

Popular Articles